论文部分内容阅读
目的分析胺碘酮联合参松养心胶囊治疗室性心律失常(VA)的疗效。方法选择2014年2月~2015年11月本院收治的60例VA病人,随机分为两组,对照组给予胺碘酮口服;观察组在对照组基础上给予参松养心胶囊治疗,比较两组治疗后1月的临床疗效及不良反应情况。结果观察组治疗总有效率86.7%,对照组为70.0%,两组对比差异有统计学意义(P<0.05);观察组不良反应率3.3%,对照组0%,两组差异无统计学意义(P>0.05)。结论参松养心胶囊联合胺碘酮治疗心律失常较胺碘酮单独治疗效果更显著,且用药相对安全,值得推广。
Objective To analyze the efficacy of amiodarone combined with Shensongyangxin Capsule in the treatment of ventricular arrhythmia (VA). Methods Sixty VA patients admitted to our hospital from February 2014 to November 2015 were randomly divided into two groups. The control group was orally administered with amiodarone. The observation group was treated with Shensongyangxin Capsule on the basis of the control group. Clinical efficacy and adverse reactions in two groups after 1 month of treatment. Results The total effective rate was 86.7% in the observation group and 70.0% in the control group, with significant difference between the two groups (P <0.05). The adverse reaction rate in the observation group was 3.3% and in the control group, there was no significant difference between the two groups (P> 0.05). Conclusion Shensong Yangxin Capsule combined amiodarone treatment of arrhythmia than amiodarone alone treatment effect is more significant, and the medication is relatively safe, it is worth promoting.